share_log

ONEONCOLOGY TO ACQUIRE LEADING UROLOGY SPECIALTY PRACTICE NETWORK

ONEONCOLOGY TO ACQUIRE LEADING UROLOGY SPECIALTY PRACTICE NETWORK

ONEONCOLOGY将收购领先的泌尿外科专业诊所网络
PR Newswire ·  08/20 07:58
  • Partnership provides additional growth capital, supported by OneOncology's investors, TPG and Cencora, to expand comprehensive high-value urology care in physician-owned practices and ambulatory surgery centers
  • Culture of physician leadership and organic growth is highly complementary to OneOncology
  • Increasing complexity of prostate, bladder, and other genitourinary cancers means partnership between OneOncology and United Urology Group will drive meaningful improvement to cancer care
  • 合作提供额外的增长资本,得到OneOncology的投资者TPG和Cencora的支持,以扩展由医生拥有的实践和门诊手术中心提供的综合高价值泌尿科护理。
  • 以医生领导和有机增长为特色的文化与OneOncology高度契合。
  • 前列腺、膀胱和其他泌尿生殖癌的复杂性不断增加,OneOncology和United Urology Group之间的合作将对癌症治疗产生有意义的改善。

NASHVILLE, Tenn. and OWINGS MILLS, Md., Aug. 20, 2024 /PRNewswire/ -- OneOncology, the fastest-growing national platform for independent oncology practices, today announced that it has agreed to acquire United Urology Group ("UUG"), one of the nation's leading urology management services organizations supporting approximately 250 physicians and advanced practice providers with more than 1,300 employees. UUG's vision is to lead the transformation of urology through its commitment to accessible, high quality, and value-based care; patient and employee satisfaction; continuous innovation; and community involvement.

2024年8月20日,田纳西州纳什维尔和马里兰州欧文斯密尔斯(PRNewswire)—OneOncology是独立肿瘤实践的最快增长的全国平台,今天宣布已同意收购United Urology Group(“UUG”),这是美国主要的泌尿科管理服务组织之一,支持约250名医生和高级实践提供者,拥有超过1,300名员工。UUG的愿景是通过致力于可访问的、高质量的、基于价值的护理、患者和员工满意度、持续创新和社区参与来引领泌尿科的变革。

OneOncology, the fastest-growing national platform for independent oncology practices, has agreed to acquire United Urology Group, one of the nation's leading urology management services organizations supporting approximately 250 physicians and advanced practice providers with more than 1,300 employees.
OneOncology是独立肿瘤实践的最快增长的全国平台之一,已同意收购United Urology Group,这是美国主要的泌尿科管理服务组织之一,支持约250名医生和高级实践提供者,拥有超过1,300名员工。

"UUG's attention and dedication to physician centricity and partnership with its leading independent practices is directly aligned with OneOncology's culture and philosophy," said Jeff Patton, MD, Chief Executive Officer, OneOncology. "We are thrilled to partner with the physician and executive leadership of United Urology Group to continue advancing urology care, including the increasingly complex treatment of genitourinary cancers."

“UUG致力于以医生为中心的文化和与其领先的独立实践合作的伙伴关系与OneOncology的文化和哲学完全一致,”Jeff Patton医学博士,首席执行官,OneOncology说。“我们很高兴与United Urology Group的医生和执行领导合作,继续推进泌尿科护理,包括越来越复杂的泌尿生殖癌的治疗。”

Urologists are critical members of the cancer care ecosystem, serving as the quarterbacks for cancer care for prostate, bladder, and other genitourinary cancers. Prostate cancer incidence rates have grown by approximately 3% per year over the last decade, creating a high unmet need for these services. In 2024, the American Cancer Society estimates there to be almost 300,000 newly diagnosed cases of prostate cancer in the United States with prostate cancer being the second-leading cause of cancer death in American men.

泌尿科医生是癌症护理生态系统的重要成员,是前列腺、膀胱和其他泌尿生殖癌症治疗的领队。近10年来,前列腺癌的发病率每年增长约3%,创造了巨大的未满足需求。2024年,美国癌症协会估计,美国将有近30万新诊断病例的前列腺癌,前列腺癌是美国男性癌症死亡的第二大原因。

"We at UUG have built something truly unique in the urologic space, offering affiliate practices the support they need to elevate their services while reducing administrative and financial burdens for physicians. I am incredibly proud of our team and excited about the opportunity to unite these two outstanding organizations. With OneOncology's proven track record of growth, we are eager to extend our fully integrated care ecosystem to more independent urology practices. We look forward to enhancing access to high-quality ancillary services for both practices and their patients," said Ian Wong, Chief Executive Officer, UUG.

“我们在泌尿学空间中建立了非常独特的东西,为合作医疗提供了所需的支持,提高了服务水平,同时减轻了医生的行政和财务负担。我为我们的团队感到非常自豪,并为将这两个杰出的组织联系在一起的机会感到兴奋。随着OneOncology业务增长的卓越记录,我们渴望将完全融合的护理生态系统扩展到更多的独立泌尿科实践中。我们期待增强独立实践和患者的高质量辅助服务的可访问性,”UUG的首席执行官Ian Wong说。

United Urology Group has demonstrated unparalleled operational leadership, integrating its affiliate practices with sophisticated technology systems and processes. This has enabled the company to broaden the breadth of ancillary service lines its affiliate practices provide by offering comprehensive, lower-cost and integrated care to its patients in its physician offices and ambulatory surgery centers. With these capabilities, UUG has created a platform for sustainable growth, partnering with its affiliated practices and providers to improve their economics while maintaining a high level of patient care.

联合泌尿医学组织展示了无与伦比的操作领导力,通过提供综合的、低成本的、整合的护理服务,在医生的办公室和门诊手术中心为患者提供了更广泛的辅助服务线。凭借这些能力,UUG已经创造了一种可持续增长的平台,与其关联的实践和提供者合作,改善其经济水平,同时保持高水平的患者护理。

"I am energized about the opportunities that this new relationship brings. The synergies between OneOncology and United Urology Group are going to allow us to enhance care to our complex urologic oncology patients and provide the ideal patient experience to all our urology patients across our expanding platform," said Geoffrey Sklar, MD, Chief Medical Officer, UUG.

“我为这种新关系所带来的机会感到兴奋。 OneOncology和United Urology Group之间的协同效应将允许我们加强对复杂泌尿肿瘤患者的护理,并为我们扩大平台的所有泌尿科患者提供理想的患者体验。”UUG的首席医疗官Geoffrey Sklar说。

Debevoise & Plimpton LLP and Sheppard Mullin served as legal counsel to OneOncology, while Ropes & Gray LLP and McGuire Woods served in the same capacity to the seller. Houlihan Lokey served as financial advisor to UUG. The transaction is expected to close by the end of 2024.

Debevoise&Plimpton LLP和Sheppard Mullin担任OneOncology的法律顾问,而Ropes&Gray LLP和McGuire Woods则作为出售方的法律顾问。Houlihan Lokey担任UUG的财务顾问。该交易预计将于2024年年底完成。

About OneOncology
OneOncology was founded by community oncologists, for community oncologists, with the mission of improving the lives of everyone living with cancer. The company's goal is to enable community oncology practices to remain independent and to improve patient access to care in their communities, all at a lower cost than in the hospital setting. Backed by TPG and Cencora, OneOncology supports its platform of community oncology practices through group purchasing, operational optimization, practice growth, and clinical innovation. The company's 1,300 cancer care providers care for approximately 787,000 patients at more than 420 sites of care nationwide. Visit for more information.

关于OneOncology
OneOncology由社区肿瘤科医生创立,旨在改善所有患有癌症的人的生活。该公司的目标是使社区肿瘤实践保持独立,并在医院设置下以较低的成本改善患者的就医条件。OneOncology由TPG和Cencora支持,通过团体采购、操作优化、实践增长和临床创新支持其社区肿瘤学实践平台。该公司的1,300名癌症护理提供者在全国超过420个护理地点为约787,000名患者提供护理。访问 了解更多信息。

About United Urology Group
United Urology Group supports a urology-specific continuum of care model for providers and patients alike. United Urology Group enables affiliate practices to focus on providing high quality, integrated, and cost-effective urologic care to their patients. More than 1,500 caring, compassionate employees are affiliated with the network, including 160+ physicians and 80+ advanced practice providers, serve 900,000+ patients a year with the goal of superior urologic care. The organization's member groups of urology practices today include Arizona Urology Specialists, located in the greater Phoenix and Scottsdale areas; Arizona Urology Specialists, located in the Tucson metro area; Chesapeake Urology, with offices located throughout Maryland and Eastern Delaware; Colorado Urology, located in the greater Denver, Boulder, and Foothills areas; and Tennessee Urology, serving patients in the greater Knoxville area and Eastern Tennessee.

关于United Urology Group
United Urology Group为提供商和患者提供尿路科的特定连续护理模式的支持。 United Urology Group使联盟实践能够专注于为其患者提供高质量、整合和具有成本效益的尿路科护理。该网络共有超过1,500名关心和有同情心的员工,包括160多名医生和80多名高级实践提供者,每年为900,000名患者提供服务,目标是提供卓越的泌尿科护理。该组织的泌尿科实践成员包括位于菲尼克斯和斯科茨代尔地区的Arizona Urology Specialists;位于图森市的Arizona Urology Specialists;遍布马里兰州和东部特拉华州的Chesapeake Urology;位于丹佛、博尔德和山麓地区的科罗拉多尿路科;以及Tennessee Urology,为位于大诺克斯维尔地区和东部田纳西州的患者提供服务。

For press inquiries, please contact:

如有媒体问题,请联系:

  • OneOncology: Eric Hoffman at [email protected]
  • United Urology Group: Severa Lynch at [email protected]
  • OneOncology:请发邮件至Eric Hoffman [email protected]
  • United Urology Group:请发邮件至Severa Lynch [email protected]

SOURCE OneOncology, LLC.

来源:OneOncology,LLC.

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发